Redica Systems

Site Intelligence

Who Really Owns the 483? A Sponsor's Guide to Shared Accountability at CMOs

July 24, 2026

Site Intelligence

Why Dashboards Can’t Save You From Pharma Supply Risk

July 17, 2026

Site Intelligence

What 2,400+ FDA 483s Reveal About Sterility Compliance

July 15, 2026

Site Intelligence

Person-in-Plant, Done Right: A Practical Framework for Sponsors and CMOs

July 10, 2026

Regulatory Intelligence

The Signals That Predict Supply Chain Disruption Before It Happens

June 26, 2026

Redica's Veeva RIM Integration Turns Regulatory Signals into Compliance Outcomes

June 17, 2026

Site Intelligence

The F&E Wake-Up Call: Why Facilities & Equipment Is Now the Fastest Growing 483 Category

June 12, 2026

FDA's One-Day Inspections in Context: What the RRA Era Already Taught Us

May 13, 2026

Regulatory Intelligence

Your Quality Team Is Flying Half the Plane. Here’s What’s Missing.

May 5, 2026

Trends

Non-Sterile Doesn’t Mean Low Risk: FDA Emphasizes Gaps in Microbial Control

October 27, 2025

Product Insights

Redica Data-as-a-Service (DaaS): Seamless Data Integration, Where You Work

September 11, 2025

Redica Systems Closes Financing to Advance Predictive Quality and Regulatory Intelligence in Life Sciences

May 15, 2025

What Is a 510(k) Submission? A Complete 2025 Guide

January 14, 2025

503B Outsourcing Facilities: A Complete 2025 Inspection-Readiness Guide

January 8, 2025

Redica Systems Successfully Completes SOC 2® Audit

December 17, 2024

Understanding MHRA UK Compliance in Pharma and MedTech

December 4, 2024

FDA Inspection Database: An Essential Tool to Prepare for FDA Inspections

November 29, 2024

Tianish Laboratories Private Limited: A Timeline of Regulatory Assessments

November 13, 2024